Stock 1167 JACOBIO PHARMACEUTICALS GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Trading Ideas Jacobio Pharmaceuticals Group Co., Ltd.

Equities

1167

KYG4987A1094

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:17 17/05/2024 BST 		5-day change 1st Jan Change
1.87 HKD +1.08% Intraday chart for Jacobio Pharmaceuticals Group Co., Ltd. +0.54% -48.34%
05-13 Jacobio Pharmaceuticals Reports Approval for Phase 3 Trial for Combination Therapy Between Glecirasib and Cetuximab MT
05-10 Jacobio Pharmaceuticals Group Co., Ltd. Receives Approval of Registrational Phase III Clinical Trial of Glecirasib (Jab-21822) and Epidermal Growth Factor Receptor Inhibitor Erbitux in Patients with Colorectal Cancer CI

Trading Ideas

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1167 Stock
  4. News Jacobio Pharmaceuticals Group Co., Ltd.
  5. Trading Ideas